Table 2.
All (Mean ± SD) |
Group-A 45° ≤ TKT0 < 60° (Mean ± SD) |
Group-B 60° ≤ TKT0 ≤ 75° (Mean ± SD) |
p | |
---|---|---|---|---|
TKT0 | 61.9 ± 11.2 | 55.7 ± 4.5 | 66.3 ± 7.9 | 0.003* |
TKT1 (in-brace) | 37.5 ± 9.1 | 35.8 ± 5.6 | 39.3 ± 8.3 | 0.087 |
TKT2 | 38.9 ± 7.3 | 37.8 ± 6.2 | 41.5 ± 6.8 | 0.0625 |
TKT3 | 41.7 ± 4.4 | 40.3 ± 7.6 | 43.3 ± 5.3 | 0.0923 |
ΔTK | 19.5 ± 5.8 | 15.5 ± 4.8 | 23.1 ± 3.6 | 0.021* |
In-brace TK% | 37.4% | 35.1% | 40.7% | 0.01§ |
TK%T3 | 31.6% | 27.7% | 34.7% | 0.005§ |
Compliant patients (%) | 84.9% | 76.3% | 90.5% | 0.022§ |
Curve reduction: ΔTK ≤ − 5° (%) | 116 (60.4%) | 45 (59.2%) | 71(61.2%) | 0.526 |
Curve stabilization: − 5° < ΔTK < 5 (%) | 57 (29.7%) | 24 (31.6%) | 33 (28.5%) | 0.065 |
Curve progression: ΔTK ≥ 5° (%) | 19 (9.9%) | 7 (9.2%) | 12 (10.4%) | 0.773 |
*Significant p value (unpaired t test)
§Significant p value (Chi-square test)